Skip to content
Subscriber Only
Business
Prognosis

J&J Seeks Vaccine Clearance, Moving U.S. Near Third Shot

  • Drugmaker says it is ready to ship doses upon authorization
  • Single-dose vaccine could help ramp up immunization effort
relates to J&J Seeks Vaccine Clearance, Moving U.S. Near Third Shot
Updated on

Johnson & Johnson asked U.S. drug regulators to clear its experimental Covid-19 vaccine for emergency use, setting off a review process that could lead to millions more doses becoming available to step up a stumbling immunization drive.

The drugmaker said in a statement Thursday that it had filed an application for an emergency-use authorization with the U.S. Food and Drug Administration. If cleared, the shot would give the U.S. a third vaccine to try to halt a pandemic that has killed more than 450,000 Americans.